Squarepoint Ops LLC Biotechnology

Squarepoint Ops LLC

  • $80.7 Billion
  • Q1 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
MRNA
Moderna, Inc.
PUT
$44.5 Million
1.57M
Q1 2025
Reduced 18.66%
NVO
Novo Nordisk A S
PUT
$38.9 Million
560K
Q1 2025
Added 451.03%
NVO
Novo Nordisk A S
CALL
$31.7 Million
457K
Q1 2025
Added 451.03%
MRNA
Moderna, Inc.
CALL
$19 Million
669K
Q1 2025
Reduced 18.66%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$17.1 Million
26.9K
Q1 2025
Added 11.56%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$12.5 Million
19.7K
Q1 2025
Added 11.56%
ADMA
Adma Biologics, Inc.
CALL
$5.76 Million
291K
Q1 2025
Reduced 0.87%
VKTX
Viking Therapeutics, Inc.
CALL
$4.03 Million
167K
Q1 2025
Added 64.21%
VRTX
Vertex Pharmaceuticals Inc
CALL
$3.64 Million
7.5K
Q1 2025
Reduced 24.16%
SRPT
Sarepta Therapeutics, Inc.
CALL
$3.49 Million
54.7K
Q1 2025
Added 732.64%
VKTX
Viking Therapeutics, Inc.
PUT
$3 Million
124K
Q1 2025
Added 64.21%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$2.78 Million
8.4K
Q1 2025
Added 6.46%
BMRN
Biomarin Pharmaceutical Inc
PUT
$2.16 Million
30.6K
Q1 2025
Added 100.35%
AXSM
Axsome Therapeutics, Inc.
PUT
$1.92 Million
16.5K
Q1 2025
Added 58.33%
EXEL
Exelixis, Inc.
CALL
$1.55 Million
42K
Q1 2025
Reduced 97.27%
BMRN
Biomarin Pharmaceutical Inc
CALL
$1.53 Million
21.7K
Q1 2025
Added 100.35%
SRPT
Sarepta Therapeutics, Inc.
PUT
$1.53 Million
24K
Q1 2025
Added 732.64%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$1.3 Million
4.8K
Q1 2025
Reduced 95.09%
VRNA
Verona Pharma PLC
PUT
$1.26 Million
19.8K
Q1 2025
New holding
AXSM
Axsome Therapeutics, Inc.
CALL
$1.07 Million
9.2K
Q1 2025
Added 58.33%
ACLX
Arcellx, Inc.
CALL
$1.03 Million
15.7K
Q4 2024
New holding
NVAX
Novavax Inc
PUT
$968,000
151K
Q1 2025
Reduced 67.39%
SWTX
Spring Works Therapeutics, Inc.
CALL
$909,000
20.6K
Q4 2024
Reduced 59.24%
KMPH
Kempharm, Inc
PUT
$869,000
176K
Q1 2025
Added 311.58%
ACLX
Arcellx, Inc.
PUT
$806,000
12.3K
Q4 2024
New holding
BBIO
Bridge Bio Pharma, Inc.
PUT
$791,000
22.9K
Q2 2024
New holding
CRSP
Crispr Therapeutics Ag
PUT
$735,000
21.6K
Q1 2025
Reduced 56.05%
PTGX
Protagonist Therapeutics, Inc
PUT
$725,000
15K
Q3 2024
Added 89.01%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$695,000
2.1K
Q1 2025
Added 6.46%
TGTX
Tg Therapeutics, Inc.
CALL
$579,000
14.7K
Q1 2025
Added 51.44%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$567,000
2.1K
Q1 2025
Reduced 95.09%
ADMA
Adma Biologics, Inc.
PUT
$486,000
24.5K
Q1 2025
Reduced 0.87%
CRSP
Crispr Therapeutics Ag
CALL
$486,000
14.3K
Q1 2025
Reduced 56.05%
TGTX
Tg Therapeutics, Inc.
PUT
$461,000
11.7K
Q1 2025
Added 51.44%
AKRO
Akero Therapeutics, Inc.
PUT
$445,000
11K
Q1 2025
New holding
TVTX
Travere Therapeutics, Inc.
CALL
$435,000
24.3K
Q1 2025
Added 1136.18%
UTHR
United Therapeutics Corp
CALL
$431,000
1.4K
Q1 2025
New holding
SMMT
Summit Therapeutics Inc.
CALL
$424,000
22K
Q4 2024
New holding
SMMT
Summit Therapeutics Inc.
PUT
$416,000
21.6K
Q4 2024
New holding
CORT
Corcept Therapeutics Inc
CALL
$354,000
3.1K
Q1 2025
New holding
BNTX
Bio N Tech Se
PUT
$336,000
3.7K
Q1 2025
Reduced 5.93%
RXRX
Recursion Pharmaceuticals, Inc.
CALL
$306,000
58K
Q1 2025
Added 44.81%
ACAD
Acadia Pharmaceuticals Inc
PUT
$274,000
16.5K
Q1 2025
Reduced 74.32%
NVAX
Novavax Inc
CALL
$231,000
36.1K
Q1 2025
Reduced 67.39%
CNTA
Centessa Pharmaceuticals PLC
CALL
$228,000
15.9K
Q1 2025
Added 59.9%
RXRX
Recursion Pharmaceuticals, Inc.
PUT
$158,000
30K
Q1 2025
Added 44.81%
SLS
Sellas Life Sciences Group, Inc.
CALL
$140,000
130K
Q1 2021
Closed
ABUS
Arbutus Biopharma Corp
CALL
$87,000
25K
Q1 2025
Reduced 90.25%
ABUS
Arbutus Biopharma Corp
PUT
$87,000
25K
Q1 2025
Reduced 90.25%
Filter Shares Options
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email